Get the Stockscreener App
19.93
2.69%
-0.55
After Hours:
19.93
Overview
News
Price History
Option Chain
Why BCS Down?
Discussions
Forecast
Stock Split
Dividend History
Barclays Plc Adr stock is traded at $19.93, with a volume of 6.14M.
It is down -2.69% in the last 24 hours and down -1.87% over the past month.
Barclays is a universal bank headquartered in the United Kingdom. It operates via five principal segments; UK (retail), UK corporate bank, private bank and wealth management, investment bank, and US consumer bank. In its UK segment, the bank provides current accounts, mortgages, savings and investment management services, credit cards, and business banking services to retail clients and small and medium-size enterprises. The international segment includes a corporate bank offering banking solutions to large corporates, a bulge-bracket global investment bank, and a credit card and payments business.
See More
Previous Close:
$20.48
Open:
$20.36
24h Volume:
6.14M
Relative Volume:
0.53
Market Cap:
$69.89B
Revenue:
$36.74B
Net Income/Loss:
$7.89B
P/E Ratio:
9.1519
EPS:
2.1777
Net Cash Flow:
$182.70B
1W Performance:
-3.39%
1M Performance:
-1.87%
6M Performance:
+42.77%
1Y Performance:
+63.49%
1-Day Range:
$19.89
$20.37
1-Week Range:
$19.89
$21.00
52-Week Range:
$12.14
$21.22
Barclays Plc Adr Stock (BCS) Company Profile
Compare BCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCS
Barclays Plc Adr
|
19.93 | 71.45B | 36.74B | 7.89B | 182.70B | 2.1777 |
|
JPM
Jpmorgan Chase Co
|
305.53 | 836.01B | 278.82B | 56.24B | 40.06B | 19.49 |
|
BAC
Bank Of America Corp
|
49.79 | 369.16B | 198.53B | 28.07B | 22.38B | 3.4147 |
|
WFC
Wells Fargo Co
|
79.89 | 255.41B | 123.22B | 20.76B | 6.16B | 5.8309 |
|
HSBC
Hsbc Holdings Plc Adr
|
67.33 | 246.55B | 142.78B | 18.74B | 105.99B | 4.9976 |
|
RY
Royal Bank Of Canada
|
145.26 | 204.55B | 96.89B | 13.73B | -34.72B | 9.4824 |
Barclays Plc Adr Stock (BCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-25 | Downgrade | Citigroup | Buy → Neutral |
| Mar-04-25 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Oct-08-24 | Initiated | Goldman | Buy |
| Sep-05-24 | Initiated | Kepler | Buy |
| May-09-24 | Initiated | Deutsche Bank | Buy |
| Oct-26-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-26-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-08-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| May-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-14-22 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Dec-06-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Mar-29-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-07-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-30-21 | Upgrade | Redburn | Neutral → Buy |
| Mar-16-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-12-21 | Upgrade | Goldman | Neutral → Buy |
| Nov-10-20 | Downgrade | Investec | Buy → Hold |
| Jul-10-20 | Upgrade | Investec | Hold → Buy |
| Mar-03-20 | Downgrade | Societe Generale | Buy → Hold |
| Feb-11-20 | Resumed | Credit Suisse | Neutral |
| Nov-26-19 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Sep-05-19 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Aug-21-19 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Apr-18-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-01-18 | Upgrade | Berenberg | Hold → Buy |
| Jun-19-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Apr-16-18 | Upgrade | Jefferies | Hold → Buy |
| Mar-29-18 | Upgrade | Investec | Hold → Buy |
| Mar-20-18 | Downgrade | Investec | Buy → Hold |
| Mar-08-18 | Upgrade | Goldman | Sell → Neutral |
| Jan-11-18 | Downgrade | Keefe Bruyette | Mkt Perform → Underperform |
| Jan-10-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-15-17 | Downgrade | Investec | Buy → Hold |
| Nov-20-17 | Upgrade | BofA/Merrill | Underperform → Buy |
| Oct-31-17 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Oct-20-17 | Upgrade | Berenberg | Sell → Hold |
View All
Barclays Plc Adr Stock (BCS) Latest News
Buy the Surge in AMD Stock After Striking Partnership with OpenAI? - The Globe and Mail
Morgan Stanley Remains a Buy on Barclays (BARC) - The Globe and Mail
Trading In London’s Blue Chip Stocks Is Surging — in New York - Bloomberg.com
Barclays files 2024 annual report with SEC - MSN
Case Updater: PCP v Barclays – Waiver of privilege | Latin America | Global law firm - Norton Rose Fulbright
SEC Fair Fund Opens $25+ Payment Claims for Barclays Investors During 2019-2022 Trading Period - Stock Titan
GlaxoSmithKline (GSK) Gets a Hold from Barclays - The Globe and Mail
Bit Digital Announces Proposed Offering of $100 Million Convertible Notes - Benzinga
Barclays Sticks to Its Buy Rating for BP p.l.c. (BP) - The Globe and Mail
HSBC Vs. BCS: Which Foreign Bank Deserves A Spot In Your Portfolio? - Barchart.com
HSBC vs. BCS: Which Foreign Bank Deserves a Spot in Your Portfolio? - The Globe and Mail
3rd UPDATE: Barclays 1st Half Net Profit +10% On Invest Bank; Shares Up - ADVFN
Rhumbline Advisers Reduces Stock Position in Barclays PLC $BCS - Defense World
MacroGenics (NASDAQ:MGNX) Now Covered by Analysts at Barclays - Defense World
Janux Therapeutics (NASDAQ:JANX) Now Covered by Barclays - Defense World
C4 Therapeutics (NASDAQ:CCCC) Now Covered by Barclays - Defense World
Summit Therapeutics (NASDAQ:SMMT) Coverage Initiated by Analysts at Barclays - Defense World
Ralph Lauren (NYSE:RL) Price Target Cut to $353.00 by Analysts at Barclays - Defense World
Merus (NASDAQ:MRUS) Now Covered by Barclays - Defense World
Protagonist Therapeutics (NASDAQ:PTGX) Now Covered by Analysts at Barclays - Defense World
Xencor (NASDAQ:XNCR) Now Covered by Analysts at Barclays - Defense World
Caxton Associates LLP Purchases New Stake in VNET Group, Inc.Unsponsored ADR $VNET - MarketBeat
Amundi Purchases Shares of 621,058 VNET Group, Inc.Unsponsored ADR $VNET - MarketBeat
Royal Bank of Canada Buys 1,705,324 Shares of VNET Group, Inc.Unsponsored ADR $VNET - MarketBeat
Barclays Touches 52-Week High: How to Approach the Stock Now? - The Globe and Mail
Fred Alger Management LLC Has $2.11 Million Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Millennium Management LLC Sells 2,898,605 Shares of VNET Group, Inc.Unsponsored ADR $VNET - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Sells 68,562 Shares of VNET Group, Inc.Unsponsored ADR $VNET - MarketBeat
Focus Partners Wealth Increases Stock Holdings in Barclays PLC $BCS - Defense World
Ellsworth Advisors LLC Invests $703,000 in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Scientech Research LLC Increases Stake in Genmab A/S Sponsored ADR $GMAB - MarketBeat
Alliancebernstein L.P. Trims Stake in Shell PLC Unsponsored ADR $SHEL - MarketBeat
LINEAGE INVESTOR NOTICE: Investor Files Class Action Lawsuit Against Lineage, Inc. and Attorneys Announce Opportunity for Investors with Substantial Losses to Lead Securities Class Action LawsuitLINE - Ariva
Alyeska Investment Group L.P. Sells 1,709,335 Shares of Endava PLC Sponsored ADR $DAVA - MarketBeat
Shell PLC Unsponsored ADR $SHEL Shares Sold by Clark Capital Management Group Inc. - MarketBeat
Shell PLC Unsponsored ADR (NYSE:SHEL) Receives $76.71 Average PT from Brokerages - MarketBeat
Permanens Capital L.P. Buys 5,859 Shares of Shell PLC Unsponsored ADR $SHEL - MarketBeat
Banque Transatlantique SA Acquires Shares of 10,150 Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Amundi Makes New $5.09 Million Investment in VNET Group, Inc. – Unsponsored ADR $VNET - Defense World
Cubist Systematic Strategies LLC Sells 2,650 Shares of Bicycle Therapeutics PLC Sponsored ADR $BCYC - Defense World
Barclays discloses 3.8% stake in Dalata Hotel Group - Investing.com
Vident Advisory LLC Buys Shares of 155,504 Autolus Therapeutics PLC Sponsored ADR $AUTL - Defense World
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Acquired by Cutter Capital Management LP - MarketBeat
Checkpoint Capital L.P. Buys Shares of 9,011 Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Cormorant Asset Management LP Lowers Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Genmab A/S Sponsored ADR $GMAB Shares Sold by Alliancebernstein L.P. - MarketBeat
Why Alibaba Stock Pumped Higher Today - The Globe and Mail
MAI Capital Management Has $52,000 Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - MarketBeat
Barclays discloses 3.81% stake in Dalata Hotel Group - Investing.com
Shell PLC Unsponsored ADR $SHEL Shares Sold by Interval Partners LP - MarketBeat
Adage Capital Partners GP L.L.C. Has $63.39 Million Holdings in Shell PLC Unsponsored ADR $SHEL - MarketBeat
Barclays Plc Adr Stock (BCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.33%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):